Janssen (Johnson & Johnson) COVID-19 Vaccine
Janssen COVID-19 Vaccine is no longer available in the U.S. All remaining U.S. government stock of Janssen COVID-19 Vaccine expired May 7, 2023. Dispose of any remaining Janssen COVID-19 Vaccine in accordance with local, state, and federal regulations.
People ages 18 years and older who received 1 dose of Janssen COVID-19 Vaccine should be considered to have received a single-dose Janssen primary series.
People ages 18 years and older who received 1 or 2 Janssen COVID-19 Vaccine dose are recommended to receive 1 bivalent mRNA dose (Moderna or Pfizer-BioNTech) at least 2 months after completion of the previous dose.
See the Interim Clinical Considerations for additional information.